Volitionrx (VNRX) Net Cash Flow (2011 - 2025)

Volitionrx has reported Net Cash Flow for 15 years, with the latest figure at $652971.0 in Q4 2025.

• For the quarter ending Q4 2025, Net Cash Flow rose 119.55% year-over-year to $652971.0; the trailing twelve-month figure through Dec 2025 stood at -$2.7 million (up 84.95% YoY), and the FY2025 full-year result was -$2.7 million, up 84.95% from the prior year.
• Net Cash Flow for Q4 2025 stood at $652971.0, up from -$2.0 million in the prior quarter.
• The five-year high for Net Cash Flow was $13.6 million in Q1 2021, with the low at -$9.0 million in Q3 2023.
• Historically, Net Cash Flow has averaged -$976706.8 across 5 years, with a median of -$1.4 million in 2023.
• The largest YoY upside for Net Cash Flow was 354.31% in 2021 against a maximum downside of 4367.05% in 2021.
• Volitionrx's Net Cash Flow stood at -$2.4 million in 2021, then plunged by 123.58% to -$5.5 million in 2022, then soared by 281.61% to $9.9 million in 2023, then tumbled by 133.7% to -$3.3 million in 2024, then jumped by 119.55% to $652971.0 in 2025.
• The last three Net Cash Flow figures came in at $652971.0 (Q4 2025), -$2.0 million (Q3 2025), and -$669448.0 (Q2 2025), per Business Quant data.